What is Osimertinib?

Category: Prescription Drugs

Most popular types: Tagrisso

false

Osimertinib is a treatment for non-small cell lung cancer.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Osimertinib

Side effect Patients
Weight loss 1

Dosages

Based on patients currently taking Osimertinib

Dosage Patients
80 mg daily 1

Why patients stopped taking Osimertinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 2
Doctor's advice 1
See all 2 patients who've stopped taking Osimertinib

Duration

Currently taking Osimertinib

Duration Patients
1 - 6 months 1

Stopped taking Osimertinib

Duration Patients
1 - 6 months 1
1 - 2 years 1

What people switch to and from

Patients started taking Osimertinib after stopping:

Treatment Patients
Erlotinib (Tarceva) 3
Chemotherapy 2
Afatinib (Gilotrif) 1

Patients stopped taking Osimertinib and switched to:

Treatment Patients
Chemotherapy 2
Pembrolizumab (Keytruda) 1
Last updated:
There are no evaluations for Osimertinib.